Position in TNGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$30,909,045
+$18,311,952 QoQ
Shares Held
1,477,488
+3.9% QoQ
Ownership
1.02%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 99.06977247869357.ToString("F0")%
Shared 0.ToString("F0")%
None 0.9302275213064336.ToString("F0")%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. TNGX ranks #75 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in TNGX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,909,045 | 1,477,488 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,597,093 | 1,421,794 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $2,115,057 | 251,793 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $2,737,256 | 534,621 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $343,207 | 250,519 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $989,012 | 320,070 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $2,633,221 | 341,977 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $2,088,102 | 243,369 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,425,377 | 179,519 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,419,727 | 143,407 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $2,176,826 | 193,324 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $179,922 | 54,194 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $298,582 | 75,591 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $209,660 | 28,919 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $83,858 | 23,166 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $83,494 | 18,432 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $119,118 | 15,715 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $96,675 | 8,837 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $23,881 | 1,847 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||